Diabetes Care 26:1752-1758, 2003
© 2003 by the American Diabetes Association, Inc.
Epidemiology/Health Services/Psychosocial Research Original Article |
Type 2 Diabetes and Subsequent Incidence of Breast Cancer in the Nurses Health Study
Karin B. Michels, SCD1,2,3,
Caren G. Solomon, MD2,
Frank B. Hu, MD2,4,
Bernard A. Rosner, PHD2,5,
Susan E. Hankinson, SCD2,3,
Graham A. Colditz, MD2,3 and
JoAnn E. Manson, MD2,3
1 Obstetrics and Gynecology Epidemiology Center, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts
2 Department of Medicine, Brigham and Womens Hospital, Boston, Massachusetts
3 Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts
4 Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts
5 Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts
OBJECTIVEHyperinsulinemia may promote mammary carcinogenesis. Insulin resistance has been linked to an increased risk of breast cancer and is also characteristic of type 2 diabetes. We prospectively evaluated the association between type 2 diabetes and invasive breast cancer incidence in the Nurses Health Study.
RESEARCH DESIGN AND METHODSA total of 116,488 female nurses who were 3055 years old and free of cancer in 1976 were followed through 1996 for the occurrence of type 2 diabetes and through 1998 for incident invasive breast cancer, verified by medical records and pathology reports.
RESULTSDuring 2.3 million person-years of follow-up, we identified 6,220 women with type 2 diabetes and 5,189 incident cases of invasive breast cancer. Women with type 2 diabetes had a modestly elevated incidence of breast cancer (hazard ratio [HR] = 1.17; 95% CI 1.011.35) compared with women without diabetes, independent of age, obesity, family history of breast cancer, history of benign breast disease, reproductive factors, physical activity, and alcohol consumption. This association was apparent among postmenopausal women (1.16; 0.981.62) but not premenopausal women (0.83; 0.481.42). The association was predominant among women with estrogen receptor-positive breast cancer (1.22; 1.011.47).
CONCLUSIONSWomen with type 2 diabetes may have a slightly increased risk of breast cancer.
Abbreviations: HR, hazard ratio SHBG, sex hormone-binding globulin

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Lajous, M.-C. Boutron-Ruault, A. Fabre, F. Clavel-Chapelon, and I. Romieu
Carbohydrate intake, glycemic index, glycemic load, and risk of postmenopausal breast cancer in a prospective study of French women
Am. J. Clinical Nutrition,
May 1, 2008;
87(5):
1384 - 1391.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Rollison, A. R. Giuliano, T. A. Sellers, C. Laronga, C. Sweeney, B. Risendal, K. B. Baumgartner, T. Byers, and M. L. Slattery
Population-based Case-Control Study of Diabetes and Breast Cancer Risk in Hispanic and Non-Hispanic White Women Living in US Southwestern States
Am. J. Epidemiol.,
February 15, 2008;
167(4):
447 - 456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. Rose, S. M. Haffner, and J. Baillargeon
Adiposity, the Metabolic Syndrome, and Breast Cancer in African-American and White American Women
Endocr. Rev.,
December 1, 2007;
28(7):
763 - 777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-F. Tian, C.-H. Chu, M.-H. Wu, C.-L. Chang, T. Yang, Y.-C. Chou, G.-C. Hsu, C.-P. Yu, J.-C. Yu, and C.-A. Sun
Anthropometric measures, plasma adiponectin, and breast cancer risk
Endocr. Relat. Cancer,
September 1, 2007;
14(3):
669 - 677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Xue and K. B Michels
Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence
Am. J. Clinical Nutrition,
September 1, 2007;
86(3):
823S - 835S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Wu, M. C. Yu, C.-C. Tseng, F. Z. Stanczyk, and M. C. Pike
Diabetes and risk of breast cancer in Asian-American women
Carcinogenesis,
July 1, 2007;
28(7):
1561 - 1566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Tworoger, A. H. Eliassen, T. Kelesidis, G. A. Colditz, W. C. Willett, C. S. Mantzoros, and S. E. Hankinson
Plasma Adiponectin Concentrations and Risk of Incident Breast Cancer
J. Clin. Endocrinol. Metab.,
April 1, 2007;
92(4):
1510 - 1516.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Eliassen, S. S. Tworoger, C. S. Mantzoros, M. N. Pollak, and S. E. Hankinson
Circulating Insulin and C-Peptide Levels and Risk of Breast Cancer among Predominately Premenopausal Women
Cancer Epidemiol. Biomarkers Prev.,
January 1, 2007;
16(1):
161 - 164.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Inoue, M. Iwasaki, T. Otani, S. Sasazuki, M. Noda, S. Tsugane, and for the Japan Public Health Center-Based Prospecti
Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan.
Arch Intern Med,
September 25, 2006;
166(17):
1871 - 1877.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A M Lorincz and S Sukumar
Molecular links between obesity and breast cancer.
Endocr. Relat. Cancer,
June 1, 2006;
13(2):
279 - 292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J Brown
The Role of Vitamin D in Multiple Sclerosis
Ann. Pharmacother.,
June 1, 2006;
40(6):
1158 - 1161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Lin, P. M. Ridker, N. Rifai, I-M. Lee, J. E. Manson, J. E. Buring, and S. M. Zhang
A Prospective Study of Hemoglobin A1c Concentrations and Risk of Breast Cancer in Women.
Cancer Res.,
March 1, 2006;
66(5):
2869 - 2875.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Bowker, S. R. Majumdar, P. Veugelers, and J. A. Johnson
Increased Cancer-Related Mortality for Patients With Type 2 Diabetes Who Use Sulfonylureas or Insulin
Diabetes Care,
February 1, 2006;
29(2):
254 - 258.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Tabaei, W. H. Herman, A. F. Jabarin, and C. Kim
Does Diabetes Care Compete With the Provision of Women's Preventive Care Services?
Diabetes Care,
November 1, 2005;
28(11):
2644 - 2649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. L. Lipscombe, J. E. Hux, and G. L. Booth
Reduced Screening Mammography Among Women With Diabetes
Arch Intern Med,
October 10, 2005;
165(18):
2090 - 2095.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. Terry, W. C. Willett, J. W. Rich-Edwards, D. J. Hunter, and K. B. Michels
Menstrual Cycle Characteristics and Incidence of Premenopausal Breast Cancer
Cancer Epidemiol. Biomarkers Prev.,
June 1, 2005;
14(6):
1509 - 1513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. T. Sorensen, L. Mellemkjaer, M. V. Skriver, T. L. Lash, J. H. Olsen, and J. A. Baron
No Excess Risk of Breast Cancer among Female Users of Systemic Glucocorticoids
Cancer Epidemiol. Biomarkers Prev.,
April 1, 2005;
14(4):
1022 - 1023.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. H. Jee, H. Ohrr, J. W. Sull, J. E. Yun, M. Ji, and J. M. Samet
Fasting Serum Glucose Level and Cancer Risk in Korean Men and Women
JAMA,
January 12, 2005;
293(2):
194 - 202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-S. Furberg, G. Jasienska, N. Bjurstam, P. A. Torjesen, A. Emaus, S. F. Lipson, P. T. Ellison, and I. Thune
Metabolic and Hormonal Profiles: HDL Cholesterol as a Plausible Biomarker of Breast Cancer Risk. The Norwegian EBBA Study
Cancer Epidemiol. Biomarkers Prev.,
January 1, 2005;
14(1):
33 - 40.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Platek, V. Krogh, A. Micheli, R. Browne, E. Meneghini, S. Sieri, H. J. Schunemann, V. Pala, M. Barba, G. E. Wilding, et al.
Serum Fructosamine and Subsequent Breast Cancer Risk: A Nested Case-Control Study in the ORDET Prospective Cohort Study
Cancer Epidemiol. Biomarkers Prev.,
January 1, 2005;
14(1):
271 - 274.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L Hilakivi-Clarke, C Wang, M Kalil, R Riggins, and R G Pestell
Nutritional modulation of the cell cycle and breast cancer
Endocr. Relat. Cancer,
December 1, 2004;
11(4):
603 - 622.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Mantzoros, E. Petridou, N. Dessypris, C. Chavelas, M. Dalamaga, D. M. Alexe, Y. Papadiamantis, C. Markopoulos, E. Spanos, G. Chrousos, et al.
Adiponectin and Breast Cancer Risk
J. Clin. Endocrinol. Metab.,
March 1, 2004;
89(3):
1102 - 1107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Cho, D. Spiegelman, D. J. Hunter, W. Y. Chen, G. A. Colditz, and W. C. Willett
Premenopausal Dietary Carbohydrate, Glycemic Index, Glycemic Load, and Fiber in Relation to Risk of Breast Cancer
Cancer Epidemiol. Biomarkers Prev.,
November 1, 2003;
12(11):
1153 - 1158.
[Abstract]
[Full Text]
|
 |
|
Copyright © 2003 by the American Diabetes Association.
|
|
| |
|